Delivery Order SPE2DR25D2104-SPE2DR26F3QVY
- Not listed
- The Defense Logistics Agency awarded a $42,494.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on May 30, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $7,114.48 to AmerisourceBergen Drug Corp for SAMSCA 30 mg tablets (10-count units) under a firm fixed-price contract. The award was made on November 10, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $6,856.70 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on November 10, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $11,022.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of SAMSCA 30 mg tablets (10-count units). This non-set-aside contract is scheduled for completion by June 17, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $21,247.20 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count packaging), with an ultimate completion date of October 16, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters...
- The Defense Logistics Agency awarded a $10,623.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) with an ultimate completion date of September 15, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SAMSCA 15 mg tablets (10 count) with a ceiling value of $10,623.60. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a $44,091.96 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of SAMSCA 30 mg tablets (10-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a non-competitive, non-set-aside award to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $44,091.96 to AmerisourceBergen Drug Corp for the supply of Samsca 30 mg tablets (10-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of SAMSCA (tolvaptan) 30 mg tablets in quantities of 10 units, with a ceiling value of $46,466.16 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QVYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,195.61 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count packaging) on December 8, 2025, with an ultimate completion date of December 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems through its comprehensive DLA contract vehicle. This global pharmaceutical support contract enables the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems worldwide. The current delivery order for SAMSCA, a vasopressin receptor antagonist used in treating hyponatremia, exemplifies the routine pharmaceutical supply fulfillment that occurs under this expansive prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 12/7/25 |